These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 12543802

  • 1. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
    Sükösd F, Kuroda N, Beothe T, Kaur AP, Kovacs G.
    Cancer Res; 2003 Jan 15; 63(2):455-7. PubMed ID: 12543802
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER.
    Genes Chromosomes Cancer; 1998 Jul 15; 22(3):200-9. PubMed ID: 9624531
    [Abstract] [Full Text] [Related]

  • 3. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M, Delahunt B, Störkel S, Grebem SK.
    Cancer Res; 2001 Jun 15; 61(12):4815-9. PubMed ID: 11406557
    [Abstract] [Full Text] [Related]

  • 4. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB, Amare Kadam PS.
    Urol Oncol; 2013 Oct 15; 31(7):1333-42. PubMed ID: 21962529
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.
    Cancer Res; 2001 Oct 01; 61(19):7277-81. PubMed ID: 11585766
    [Abstract] [Full Text] [Related]

  • 6. [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].
    Shuin T, Kamata M, Ashida S.
    Gan To Kagaku Ryoho; 2002 Oct 01; 29(10):1719-25. PubMed ID: 12402420
    [Abstract] [Full Text] [Related]

  • 7. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM.
    Cancer Res; 2003 Jul 01; 63(13):3724-8. PubMed ID: 12839965
    [Abstract] [Full Text] [Related]

  • 8. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
    Martinez A, Fullwood P, Kondo K, Kishida T, Yao M, Maher ER, Latif F.
    Mol Pathol; 2000 Jun 01; 53(3):137-44. PubMed ID: 10897333
    [Abstract] [Full Text] [Related]

  • 9. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M, Lott ST, Wong P, El-Naggar A, Tucker S, Killary AM.
    Cancer Res; 1999 May 01; 59(9):2182-9. PubMed ID: 10232606
    [Abstract] [Full Text] [Related]

  • 10. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
    Xiao Z, Zhang J, Zheng S, Li C, He Z, Cheng S, Gao Y.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1375-7. PubMed ID: 12509916
    [Abstract] [Full Text] [Related]

  • 11. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B, Rodríguez-Perales S, Martínez-Delgado B, Otero I, Robledo M, Martínez-Ramírez A, Ruiz-Llorente S, Urioste M, Cigudosa JC, Benítez J.
    Hum Genet; 2003 Feb 25; 112(2):178-85. PubMed ID: 12522559
    [Abstract] [Full Text] [Related]

  • 12. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
    Li L, An Q, Feng X.
    Zhonghua Yi Xue Za Zhi; 2001 Apr 10; 81(7):399-401. PubMed ID: 11798905
    [Abstract] [Full Text] [Related]

  • 13. Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.
    Gayrard N, Cacheux V, Iborra F, Mourad G, Argilés A.
    Arch Pathol Lab Med; 2008 Jun 10; 132(6):965-73. PubMed ID: 18517280
    [Abstract] [Full Text] [Related]

  • 14. Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.
    Moch H, Schraml P, Bubendorf L, Richter J, Gasser TC, Mihatsch MJ, Sauter G.
    Cancer Res; 1998 Jun 01; 58(11):2304-9. PubMed ID: 9622063
    [Abstract] [Full Text] [Related]

  • 15. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M, Yao M, Ishikawa I, Kishida T, Nagashima Y, Kondo K, Nakaigawa N, Hosaka M.
    Genes Chromosomes Cancer; 2002 Dec 01; 35(4):359-64. PubMed ID: 12378530
    [Abstract] [Full Text] [Related]

  • 16. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K, Esumi M, Ishida H, Okada K.
    J Urol; 1999 Aug 01; 162(2):614-8. PubMed ID: 10411097
    [Abstract] [Full Text] [Related]

  • 17. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas.
    Lubinski J, Hadaczek P, Podolski J, Toloczko A, Sikorski A, McCue P, Druck T, Huebner K.
    Cancer Res; 1994 Jul 15; 54(14):3710-3. PubMed ID: 8033088
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma.
    Igarashi H, Esumi M, Ishida H, Okada K.
    Cancer; 2002 Jul 01; 95(1):47-53. PubMed ID: 12115316
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient].
    Liu N, Gong K, Zhang N, Guo HF, Na X, Wu G, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2005 Jan 15; 43(2):115-7. PubMed ID: 15771820
    [Abstract] [Full Text] [Related]

  • 20. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST, Chandler DS, Curley SA, Foster CJ, El-Naggar A, Frazier M, Strong LC, Lovell M, Killary AM.
    Cancer Res; 2002 Apr 01; 62(7):1952-5. PubMed ID: 11929809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.